产品分类
Product Category详细介绍
| 品牌 | absin | CAS | 442908-10-3 |
|---|---|---|---|
| 分子式 | C16H15N7O | 纯度 | 98% |
| 分子量 | 321.34 | 货号 | abs47028016 |
| 规格 | 1mg | 供货周期 | 现货 |
| 主要用途 | is an adenosine A2a antagonist | 应用领域 | 化工,生物产业,农林牧渔,制药/生物制药,综合 |
Vipadenant 442908-10-3
| 产品描述 | |
| 描述 | Vipadenant(BIIB-014) is an adenosine A2a antagonist with Ki of 1.3 nM; less potent for A1(Ki=69 nM). |
| 纯度 | 98% |
| 储存/保存方法 | Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution. |
| 基本信息 | |
| 可溶性/溶解性 | 10 mM in DMSO |
| 生物活性 | |
| 靶点 | Adenosine Receptor |
| In vivo(体内研究) | Vipadenant (0.3-30 mg/kg) produces a dose-dependent reduction in catalepsy. Vipadenant (10 mg/kg) does not produce any statistically significant dyskinetic episodes in 6-OHDA-lesioned rats during a 19-day dosing regimen. In the mouse and rat haloperidol-induced hypolocomotion models, vipadenant has a minimum effective dose of 0.1 and 1 mg/kg, respectively. Vipadenant (3 and 10 mg/kg, p.o.) is able to increase contralateral rotations in 6-OHDA lesioned rats. |
| 参考文献 | |
| 参考文献 |
|
| 研究领域 | |
| 研究领域 | Drug DiscoverySmall Molecule DrugLead Compound Discovery |
产品咨询